Study to Evaluate the Physiological Effects on the Skin of 3 Food Supplements Versus Placebo in 40-60 Years Old Female Subjects
NCT ID: NCT06254209
Last Updated: 2024-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
132 participants
INTERVENTIONAL
2023-11-06
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Skin parameters measured are: the firmness of the skin and other biomechanical skin properties (elasticity, tonicity, density), cellulitis visibility, radiance complexion, skin condition (microrelief, skin barrier function and moisturizing)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity
NCT06146140
Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo
NCT06727292
Evaluation of Skin Attributes Following Dietary Supplement Consumption
NCT03487965
Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults
NCT02525224
The Effects of a Longevity Supplement on Aging and Photoaging
NCT05262036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Maltodextrin
Placebo
Maltodextrin included in capsules for daily administration
Verum1
Combination of clove (Syzygium aromaticum) and immortelle (Helichrysum italicum) extracts
Botanicals extracts
Powder included in capsules for daily administration
Verum2
Olive fruit extract (Olea europaea)
Botanicals extracts
Powder included in capsules for daily administration
Verum3
Hibiscus flower extract (Hibiscus sabdariffa)
Botanicals extracts
Powder included in capsules for daily administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Botanicals extracts
Powder included in capsules for daily administration
Placebo
Maltodextrin included in capsules for daily administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Phototype II to IV (Fitzpatrick)
* Visual skin radiance score (face) ≤ 7 (0 to 9 points numeric scale)
* Tactile skin firmness score (cheek) ≤ 7 (0 to 9 points numeric scale)
* Visual cellulite score (thigh) ≥ 3 (0 to 9 points numeric scale)
Exclusion Criteria
* Subjects presenting imperfections on the test sites
* Pregnant or who are planning to become pregnant
* Medication or condition that may interfere with tested outcomes
40 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nexira
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intertek
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
M. Vayssiere, Medical doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COS04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.